Forskningsradar
← Alla bevakningsområden

Life Sciences

1736 artiklar · sida 55 av 70

🇸🇪 Endast svenska
4.1

Researchers have mapped how a critical brain protein called EAAT2 malfunctions in neurodegenerative diseases, opening pathways for both new treatments and diagnostic tools. The work could enable earlier detection and intervention for ALS and Alzheimer's—conditions that cost healthcare systems billions annually and affect millions worldwide.EN

2023-01-01 · JOURNAL OF MEDICINAL CHEMISTRY · , , et al.
4.1

Swedish researchers used PCR analysis to map the genetic makeup of mpox cases during the 2022 outbreak, providing a technical foundation for tracking virus spread and variants. The work supports public health agencies and pharmaceutical companies developing diagnostics and vaccines by establishing what strains circulated in Northern Europe.EN

2023-01-01 · EMERGING INFECTIOUS DISEASES · , , et al.
4.1

A new clinical trial found that Lactobacillus crispatus probiotics—delivered orally and vaginally—may improve vaginal health outcomes. The finding could reshape how healthcare systems and pharmaceutical companies approach bacterial infections in women, potentially reducing reliance on antibiotics and opening a new market segment for microbiome-targeted therapeutics.EN

2023-01-01 · BENEFICIAL MICROBES · , , et al.
4.1

Researchers have identified dietary factors that appear to influence whether people develop tinnitus—the persistent ringing in ears that affects millions. The findings could reshape how doctors counsel patients and open a new market for preventive nutritional interventions targeting this common condition.EN

2023-01-01 · NUTRIENTS · , , et al.
4.1

Researchers identified how inherited genetic variants affect a woman's risk of developing cancer in the opposite breast after an initial diagnosis, and influence survival outcomes. The finding could reshape how doctors screen and monitor high-risk patients, potentially triggering changes in clinical protocols and genetic testing strategies across oncology practices.EN

2023-01-01 · AMERICAN JOURNAL OF HUMAN GENETICS · , , et al.
4.1

Researchers have discovered that disruptions in a single gene—retinoic acid receptor beta—trigger vastly different clinical outcomes across patients, from mild to severe presentations. The finding could reshape how doctors diagnose genetic disorders and predict patient outcomes, potentially enabling personalized treatment strategies where one genetic diagnosis no longer means one predetermined disease course.EN

2023-01-01 · GENETICS IN MEDICINE · , , et al.
4.1

Researchers discovered that SARS-CoV-2 infections strip away m6A methylation, a chemical tag that regulates how cells read their genetic instructions. The finding could explain why different variants trigger varying immune responses and may point toward new therapeutic targets for treating severe COVID and other viral infections.EN

2023-01-01 · GENOME RESEARCH · , , et al.
4.1

Bimekizumab maintained its effectiveness and safety profile over two years in patients with moderate to severe plaque psoriasis, according to interim results from the BE RADIANT trial. The finding could influence treatment guidelines and market positioning for this biologic therapy in a competitive psoriasis drug market.EN

2023-01-01 · JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY · , , et al.
4.1

A new study reveals that people treated for congenital adrenal hyperplasia face elevated risks of heart disease, stroke, and metabolic disorders in adulthood—even when hormone treatment appears well-controlled. The finding suggests current treatment protocols may need revision to prevent costly long-term complications in a growing patient population.EN

2023-01-01 · ENDOCRINE · , , et al.
4.1

Researchers have identified how obesity fundamentally alters natural killer cells—a critical part of the immune system—within fatty tissue, revealing distinct cellular patterns linked to excess weight. The findings could reshape how companies develop obesity treatments and diagnostics, potentially targeting these immune changes rather than weight alone.EN

2023-01-01 · FRONTIERS IN IMMUNOLOGY · , , et al.
4.1

Scientists have identified two previously unknown bacteria species in the Baltic Sea, expanding the catalog of marine microorganisms that influence ocean chemistry and nutrient cycles. The discovery matters for biotech firms developing marine-based products and policymakers managing coastal water quality.EN

2023-01-01 · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · , , et al.
4.1

Researchers using genetic analysis found that FGF21, a compound already in clinical trials for liver disease, may also protect kidney function and slow chronic kidney disease progression. The finding could open a new market for the drug and offer millions of CKD patients an additional treatment option.EN

2023-01-01 · METABOLISM-CLINICAL AND EXPERIMENTAL · , , et al.
4.1

Swedish researchers found that current clinical guidelines for preventing aortic dissection in Turner syndrome patients miss 83% of high-risk cases. A new measurement based on absolute aortic diameter catches 92% of cases, potentially preventing life-threatening emergencies and reducing unnecessary interventions across this patient population.EN

2023-01-01 · INTERNATIONAL JOURNAL OF CARDIOLOGY · , , et al.
4.1

A new study finds that faces showing strong emotions penetrate the brain's natural visual suppression mechanisms more effectively than neutral expressions. The finding could inform design of safety systems, threat-detection algorithms, and interfaces where emotional recognition matters—from airport security to mental health monitoring platforms.EN

2023-01-01 · EMOTION · , , et al.
4.1

A European research collaboration has documented two decades of advances in understanding and treating mastocytosis, a rare immune disorder that affects thousands. The milestone report suggests improved diagnostic and management approaches that could reshape how pharmaceutical companies and healthcare systems address uncommon allergic and hematologic diseases.EN

2023-01-01 · JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE · , , et al.
4.1

Researchers found that a class of experimental drugs can reprogram how cancer cells burn fuel, potentially offering a new treatment path for medulloblastoma, the most common malignant brain tumor in children. The finding could accelerate development of therapies targeting a genetic driver present in about 30% of cases.EN

2023-01-01 · SCIENTIFIC REPORTS · , , et al.
4.1

Researchers have charted how a specific type of neuron in the hypothalamus—a brain region governing appetite and energy use—connects to other parts of the brain. The findings could unlock new drug targets for obesity and metabolic disorders, a market opportunity worth billions as these conditions affect hundreds of millions globally.EN

2023-01-01 · ACTA PHYSIOLOGICA · , , et al.
4.1

Researchers identified a protein inside kidney cells that prevents recovery from acute kidney injury and can trigger permanent kidney disease. Blocking this protein—even days after injury occurs—restored kidney function in mice, suggesting a new treatment window for a condition affecting millions globally and costing billions in healthcare spending.EN

2023-01-01 · JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY · , , et al.
4.1

Researchers have developed scAEGAN, a machine-learning system that reconciles incompatible single-cell genomics datasets into a unified format. The breakthrough could slash time and cost for biotech firms and research institutions analyzing cellular data from multiple sources, a growing bottleneck as genomic studies proliferate.EN

2023-01-01 · PLOS ONE · , , et al.
4.1

Researchers tracked pregnancy outcomes and fertility preservation methods for young women with Turner syndrome, a genetic condition affecting about 1 in 2,500 girls. The findings could reshape clinical protocols and expand family-planning choices for this population, with implications for reproductive medicine practices and healthcare policy.EN

2023-01-01 · FRONTIERS IN ENDOCRINOLOGY · , , et al.
4.0

Scientists have identified the optimal pH level for hypochlorite-based disinfectants to kill antibiotic-resistant spores while maintaining shelf stability. The finding could improve hospital and industrial cleaning protocols while reducing corrosive damage to surfaces and packaging.EN

2025-01-01 · BMC Microbiology · , , et al.
4.0

Researchers have developed a faster way to sort through large, multifaceted datasets common in drug discovery and clinical diagnostics. The approach automates what previously required researchers to manually build and compare dozens of separate analyses, potentially accelerating how quickly biotech companies and hospitals can identify disease signatures or drug candidates.EN

2025-01-01 · Journal of Chemical Information and Modeling · , , et al.
4.0

Researchers found that combining sound with visual displays of data improves how quickly and accurately analysts understand complex information. The finding could reshape how companies design tools for financial traders, medical diagnosticians, and other professionals who make time-critical decisions based on large datasets.EN

2025-01-01 ·
4.0

A new open-access guide synthesizes decades of ethical debate around germline gene editing—the permanent alteration of human DNA passed to future generations. For biotech companies, regulators, and investors, the book offers a roadmap of the moral arguments that will shape policy, funding decisions, and public acceptance of this technology.EN

2025-01-01 · ,
4.0

Researchers have created a method to extract overlooked information from widely-used single-cell sequencing data, revealing how cells organize their DNA during division. The discovery could improve disease detection and help pharma companies better understand cell behavior in drug development.EN

2025-01-01 · Nucleic Acids Research · , , et al.